Trial intelligence / Profile preview

Megestrol acetate vs dexamethasone for chemotherapy-induced nausea and vomiting

ChiCTR2000037447Phase 4Not yet recruiting

Sponsor
West China Hospital of Sichuan University
Start
Aug 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in chemotherapy-induced nausea and vomiting (CINV) comparing Dex + placebo with Megestrol acetate + Dex (2 arms). Primary endpoint: Nausea and vomiting. Planned start Aug 2020; status: not yet recruiting.

02

Drugs

megestroldexamethasone
03

Conditions

chemotherapy-induced nausea and vomiting (CINV)

Beyond the preview

Go deeper on ChiCTR2000037447.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000037447.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call